(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMPOSIÇÃO FARMACÊUTICA E COMPOSTO PARA FABRICAÇÃO DA MESMA PARA TRATAMENTO DE NEFROPATIA DIABÉTICA COM UM ESTIMULANTE DE SGC

Em ExigênciaInvention PatentPCT · US2020057741

Application data

Number

112022008276

Type

Invention Patent

Filing

10/28/2020

Publication

07/26/2022

PCT

US2020057741

Progress at the INPI

Technical opinion to answer
  1. Filing10/28/20
  2. Publication07/26/22
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 02/18/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

CYCLERION THERAPEUTICS, INC.

US

See this company's full portfolio

Inventors

H. P. (pessoa física)

US

P. T. (pessoa física)

US

Technical data

Priority claims

US

62/927,454 · 10/29/2019

US

62/993,972 · 03/24/2020

Abstract

RATAMENTO DE NEFROPATIA DIABÉTICA COM UM ESTIMULANTE DE sGC. A presente invenção refere-se a um método para o tratamento de indivíduos apresentando nefropatia diabética pela administração de certas dosagens do Composto I, um estimulante de ciclase guanilato solúvel (sGC), ou separadamente ou em terapia de combinação.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Parecer de pré-exame

#6.23

02/18/2026

RPI 2876

Notificação de entrada na fase nacional - PCT

#1.3

07/26/2022

RPI 2690

Alteração de dados cadastrais

#1.1

05/10/2022

RPI 2679

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.